The Catholic University of Korea is a private Roman Catholic institution of higher education in South Korea. It was established in 1855. The Catholic University of Korea operates campuses in Seoul and in the neighboring Bucheon City.

During the past decade, The Catholic University of Korea conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Catholic University of Korea" #1 sponsor was "Seoul National University Hospital" with 2 trials, followed by "Seoul Retina Investigator Group" with 2 trials sponsored, "Ariad Pharmaceuticals" with 1 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored and "CG Oncology, Inc." with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Catholic University of Korea" #1 collaborator was "Chungnam National University" with 2 trials as a collaborator, "The Catholic University of Korea" with 2 trials as a collaborator, "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator, "Basilea Pharmaceutica International Ltd" with 1 trials as a collaborator and "Central and Eastern European Oncology Group" with 1 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "The Catholic University of Korea" are "Lung Cancer" (2 trials), "Type 2 Diabetes" (2 trials), "Addictive Behavior" (1 trials), "Adolescent Problems" (1 trials) and "Advanced Malignancies" (1 trials). Many other conditions were trialed in "The Catholic University of Korea" in a lesser frequency.

Most popular intervention types in "The Catholic University of Korea" are "Drug" (13 trials), "Other" (4 trials), "Biological" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Rituximab" (2 trials), "Bendamustine" (1 trials), "Brigatinib" (1 trials) and "CG0070" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Catholic University of Korea" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The Catholic University of Korea". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in The Catholic University of Korea, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Catholic University of Korea, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".